Insurance company The Travelers Companies (NYSE:TRV) was upgraded at Piper Sandler after stronger-than-expected Q4 results, ...

Fintel reports that on January 24, 2025, Piper Sandler upgraded their outlook for Travelers Companies (NYSE:TRV) from Neutral ...

In a report released today, Arvind Ramnani from Piper Sandler maintained a Hold rating on PayPal Holdings (PYPL – Research Report), with a ...

Fintel reports that on January 23, 2025, Piper Sandler initiated coverage of Bright Minds Biosciences (NasdaqCM:DRUG) with a ...

Pets insurance company Trupanion (NASDAQ:TRUP) was upgraded at Piper Sandler on improving investor sentiment and several ...

In a report released today, Nathan Race from Piper Sandler maintained a Buy rating on Wintrust Financial (WTFC – Research Report), with a price ...

Tesla remains the “top buy-and-hold” stock for analysts at Piper Sandler, who massively raised their price target for the ...

Shares of Travelers (NYSE: NYSE:TRV) climbed 1% as Piper Sandler shifted its stance on the insurance giant, upgrading the stock from Neutral to Overweight and significantly raising the price target ...

Elon Musk's Tesla could deliver a choppy H1 given tailwinds from Donald Trump's EV policies, uncertainties in deliveries, and gross margin.

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 14.59% ...

Tesla (TSLA) slips as President Trump considers eliminating EV tax credits and subsidies, while Piper Sandler analysts raise ...

Intra-Cellular Therapies Inc (ITCI) stock saw a modest uptick, ending the day at $126.5 which represents a slight increase of $0.30 or 0.24% from the prior close of $126.2. The stock opened at $126.64 ...